Copyright 2018 | MRI Lawyers | All Rights Reserved.

Call (800) 348-1552

Are you suffering health problems as a result of Gadolinium toxicity after an MRI?

FDA Warns of Gadolinium Adverse Effects  

Gadolinium deposition disease  

 Gadolinium storage condition

 Injuries such as:

The Food and Drug Administration recently warned that gadolinium-based contrast agents can stay in the body, including the brain, for months or years after an individual has a MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography). Many patients who undergo MRIs or MRAs are injected with contrast agents or dyes containing gadolinium, a heavy metal. Gadolinium-based contrast agents (GBCAs) are used to enhance the image of internal organs, blood vessels, and tissues created by magnetic resonance imaging. But concern is growing about gadolinium and the long-term effects of the heavy metal on the body and brain. The FDA is requiring manufacturers to add warning labels to gadolinium-based contrast agents to warn of the potential risk of gadolinium retention, specifically regarding the increased risk when "linear" GBCAs are used.

Find out if you have an gadolinium toxicity case. 

Find out if you have an gadolinium toxicity case. 

Please give us some information so we can contact you within 48 hours:

We will contact you within 48 hours.

Patients have filed gadolinium toxicity lawsuits. More lawsuits are likely as patients recognize they may suffer from health conditions related to gadolinium. If you have been injected with gadolinium contrast agent as part of an MRI and experienced health problems afterward, and you have normal or near-normal kidney function, you may have a right to seek compensation. Legal time limits apply, so it is important to contact us now for a free discussion of your legal rights.

Who we are

When you choose a personal injury or disability lawyer, you need to be represented by someone you can trust and who will treat your case with the importance that it deserves. At MRI Lawyers, we are driven by a single goal: to protect the rights of our clients.

This means getting clients the money and benefits that they deserve. We ensure that our clients are protected at every step of the claims process. We know that coping with an injury or disability is hard enough without added legal stress. Let us take the burden off your shoulders and navigate the legal system on your behalf.

We HAVE BEEN Driven by a single goal for over 30 years:
to protect the rights of our clients


Let's begin the process with a FREE case review. Submit the form above.

Do you have:

Tradename Active Ingredient Applicant Indication Chemical Subclass Approval Year
Magnevist gadopentetate dimeglumine, Gd-DTPA Bayer Neuro, Body Linear 1988
Omniscan gadodiamide, Gd-DPTA-BMA GE Neuro, Body Linear 1993
MultiHance gadobenate dimeglumine, Gd-BOPTA Bracco Neuro, Vascular Linear 2004
Eovist gadoxetate disodium, Gd-EOB-DTPA Bayer Liver Linear 2008

Pain and burning sensation in your arms, legs, or torso;

Cognitive difficulties such as "brain fog" or persistent headaches;

Skin changes such as thickening or hardening;

Muscle or joint pain; or

Tightness in your hands and feet.

In patients with normal to near-normal kidney function, the retention of gadolinium in the body after a MRI/MRA can be associated with Gadolinium Deposition Disease ("GDD"). GDD is a condition involving bone pain, burning tissue pain, and cognitive effects such as brain fog, memory impairment and persistent headaches. Gadolinium storage condition involves excess amounts of gadolinium in the body. The FDA warned doctors to minimize repeated MRIs using gadolinium contrast agents when possible.

There are a number of FDA-approved Linear Gadolinium-based contrast agents or GBCAs on the market.

Aylstock Firm

Bryan F. Aylstock

Mr. Aylstock earned a Bachelor of Arts degree in history from the University of North Florida in 1992 (magna cum laude), and graduated number one in his law school section at the University of Florida in May, 1995. After completing law school, he was accepted as an Honors Intern at the United States Department of Justice.

Jason Richards

Mr. Richards, a partner with the firm, focuses his practice on insurance, pharmaceutical/ products liability and class action litigation. He holds a master’s degree from the University of Colorado, a law degree from the John Marshall Law School, and a master of laws degree in health law from DePaul University College of Law.

Justin G. Witkin

Mr. Witkin received his B.S. in finance from Florida State University in 1992, and graduated with high honors from the University of Florida College of Law in 1995. Mr. Witkin received American Jurisprudence Awards in Torts, Income Tax, Antitrust and Social Science, and was installed as a member of the Order of the Coif.

Daniel Thornburgh

Daniel Thornburgh, a partner with the firm, earned his Bachelor of Arts from the University of West Florida where he studied Legal Administration. After undergraduate studies, Mr. Thornburgh worked as a mass tort paralegal and law clerk for the firm.

Greg Bubalo

Over the first two decades of his legal career, Gregory J. Bubalo had developed a solid reputation as a defense-side corporate litigator and medical malpracticedefense lawyer. But when Becker Law Office founder Gary Becker asked him to cross over to do plaintiff work in 1999, Bubalo saw a grand opportunity to advance his legal career into an exciting new area. He’s never doubted that decision.

Bubalo / Becker

Kate Dunnington

Dunnington joined in the summer of 2015 and currently handles mass injury cases, as well as personal injury cases. "I am intrigued by the science involved with mass tort litigation, and am fulfilled by helping people who have suffered due to the use of pharmaceuticals."

How to Know if You May Have Gadolinium Deposition Disease  

—Are you experiencing a number of the following symptoms?

Intense burning of the skin

Intense pain in bones

Brain fog, confused thinking

Muscle vibrations, pins and needles sensation

Head pain

Arm and leg skin discoloration and pain

Persistent metallic taste

It is critical that patients have at least three of the symptoms to make a confirmed diagnosis. 

—Did your symptoms appear within a month after the injection of gadolinium-based agents used as part of an MRI? The timing of your symptoms is also very important to the proper diagnosis of Gadolinium Deposition Disease. The symptoms may arise immediately of the MRI or they may develop over several weeks after the test.

—Are your symptoms new since being injected with gadolinium-based dye or contrast agent? If the symptoms were pre-existing before the MRI, they may not be related to Gadolinium Deposition Disease.

Gadolinium Deposition Disease requires that there must be evidence of gadolinium in the body.

(Swipe to scroll horizontally.)